- Issuer ticker
-
ITRM
- Reported as of
-
18 Nov 2025
- Net transaction value
-
+$2,191
- SEC form
-
4
- Accepted by SEC
-
20 Nov 2025, 07:00:04 UTC
Filing notes and source
Key filing fact
Michael W. Dunne filed Form 4 for Iterum Therapeutics plc (ITRM) on 20 Nov 2025.
Key facts
- This page summarizes Michael W. Dunne's Form 4 filing for Iterum Therapeutics plc (ITRM).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 20 Nov 2025, 07:00.
Change
- Previous filing in this sequence was filed on 12 Aug 2025.
- Current net transaction value: +$2,191.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
Ownership activity is grounded in SEC Form 4 disclosures.
View source filing
Reporting Owners (1)
CIK 0001553593
Primary reporting owner
Dunne Michael W.
- Relationship
-
Director
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
ITRM
transaction
Ordinary Shares
Purchase
- Transaction value
- $2,191
- Shares
- +6,000
- Change %
- +2.6%
- Price
-
$0.3652
- Shares after
- 241,001
- Date
- 18 Nov 2025
- Ownership
- Direct
* marks a reported price that did not pass the local price check.